Olfactory receptor family 6 subfamily C member 5B (Or6c5b) represents a crucial component within the complex machinery of olfaction, orchestrating the initial steps in the sensory perception of odors. Belonging to the expansive family of G-protein-coupled receptors (GPCRs), Or6c5b shares a structural framework characterized by seven transmembrane domains. This receptor, arising from single coding-exon genes, partakes in the intricate process of odorant signal transduction. Olfactory receptors, including Or6c5b, are embedded within the sensory neurons of the nasal epithelium, where they encounter and interact with a myriad of odorant molecules. The recognition of these odorants by Or6c5b initiates a cascade of events, leading to the activation of downstream signaling pathways, eventually culminating in the perception of distinct smells. Or6c5b's involvement in G protein-mediated transduction of odorant signals underscores its role as a molecular switch that translates external stimuli into neuronal responses. These responses trigger intricate neural pathways, leading to the perception of specific odors. As a member of the largest gene family in the genome, the olfactory receptor gene family, Or6c5b contributes to the diversity of odorant detection capabilities, allowing organisms to navigate and interpret their olfactory environment. The independent nomenclature assigned to olfactory receptors in different organisms reflects the unique and intricate nature of this gene family, emphasizing its evolutionary significance in adapting to diverse olfactory landscapes.
In the realm of inhibition, the modulation of Or6c5b's function takes various forms, with inhibitors acting through distinct yet interconnected cellular pathways. The inhibition of retinoic acid signaling disrupts the expression of odorant receptors, impacting Or6c5b indirectly. Direct inhibitors competitively bind to the receptor, hindering the binding of odorant molecules and preventing subsequent G protein-mediated transduction. Other inhibitors target critical pathways such as cAMP, MAPK, calcium signaling, and phosphoinositide signaling, influencing downstream events in olfactory signal transduction and thereby affecting Or6c5b function. The diversity in these inhibition mechanisms reflects the multifaceted nature of olfactory signal processing, shedding light on potential avenues for further exploration into the intricate regulatory processes governing olfaction. In summary, understanding the function of Or6c5b elucidates its pivotal role in the perception of odors, while the diverse mechanisms of inhibition underscore the intricate web of molecular events that orchestrate olfactory signal transduction, contributing to our comprehension of this complex sensory system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Inhibits Or6c5b indirectly by disrupting retinoic acid signaling, crucial for olfactory receptor expression. Bexarotene antagonizes retinoic acid receptors, modulating the expression of odorant receptors and influencing Or6c5b function by downregulating the receptor gene. | ||||||
Diphenhydramine hydrochloride | 147-24-0 | sc-204729 sc-204729A sc-204729B | 10 g 25 g 100 g | $52.00 $84.00 $124.00 | 4 | |
Inhibits Or6c5b directly by blocking the binding of odorant molecules to the receptor, preventing G protein-mediated transduction. Diphenhydramine competitively binds to the receptor, hindering its activation and subsequent signal transduction, thereby inhibiting Or6c5b function. | ||||||
Pirenzepine Dihydrochloride | 29868-97-1 | sc-204197 | 100 mg | $69.00 | 3 | |
Inhibits Or6c5b indirectly by suppressing the cAMP signaling pathway, essential for olfactory signal transduction. Pirenzepine inhibits adenylyl cyclase, the enzyme responsible for cAMP production, hampering the transduction of odorant signals and leading to indirect inhibition of Or6c5b. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Inhibits Or6c5b indirectly by disrupting calcium signaling, essential for olfactory signal transduction. Nifedipine is a calcium channel blocker that influences intracellular calcium concentrations, playing a pivotal role in modulating various steps in the olfactory signaling cascade and thereby influencing Or6c5b function. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Inhibits Or6c5b indirectly by disrupting calcium signaling, essential for olfactory signal transduction. (±)-Bay K 8644 is a calcium channel agonist that influences intracellular calcium concentrations, playing a pivotal role in modulating various steps in the olfactory signaling cascade and thereby influencing Or6c5b function. | ||||||
TAK-733 | 1035555-63-5 | sc-364630 sc-364630A | 5 mg 10 mg | $340.00 $640.00 | 1 | |
Inhibits Or6c5b indirectly by targeting the MAPK pathway involved in olfactory receptor signal transduction. TAK-733 is a MEK inhibitor that disrupts the MAPK signaling cascade, altering downstream events and influencing Or6c5b function by modulating the cellular processes associated with odorant perception. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Inhibits Or6c5b indirectly by disrupting calcium signaling, essential for olfactory signal transduction. W-7 is a calmodulin antagonist that influences intracellular calcium concentrations, playing a pivotal role in modulating various steps in the olfactory signaling cascade and thereby influencing Or6c5b function. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
Inhibits Or6c5b indirectly by suppressing the cAMP signaling pathway, essential for olfactory signal transduction. SQ 22536 is an adenylate cyclase inhibitor that hampers cAMP production, interfering with the transduction of odorant signals and leading to indirect inhibition of Or6c5b. | ||||||